Capital Flow Monitor · Sponsors · CIK 1829255
Halia Therapeutics, Inc.
3900 N. Traverse Mountain Blvd, Lehi, UT, 84043 · 385-355-4315
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$20.0M
Sold
$337K
% sold
1.7%
Investors
5
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-07-16 | D ·current | 506(b) | $20.0M | $337K | 1.7% | 5 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Jeffrey Burton — Executive Officer, Lehi, UT
- David Bearss — Executive Officer / Director, Lehi, UT
- Jared Bearss — Director, Lehi, UT
- John S.K. Kauwe — Director, Lehi, UT
- Todd Pedersen — Director, Lehi, UT
- Gary B. Sabin — Director, Lehi, UT
- Jim Savas — Director, Lehi, UT
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.